About the Sarcoma Program Team
The Importance of Multidisciplinary Care
Because the type of treatments recommended depends upon the nature of the sarcoma and its stage of progression, careful review of the tissue removed during a surgical biopsy is essential. A pathologist experienced in diagnosing sarcomas as well as radiologists, oncologists, and surgeons who primarily treat sarcomas should review the biopsied tissue.
Due to the complex nature of these kinds of cancers, complete diagnosis and treatment, planning by a multi-disciplinary team of expert cancer specialists is essential to determine the best treatment options for you.
What Sets Us Apart?
Pennsylvania Hospital's Bone and Soft Tissue Sarcoma Program is one of the few multi-specialty programs of its kind. Our service is distinguished in many ways:
- Sarcoma specialists who are recognized experts in the treatment of bone or soft tissue sarcomas and have developed some of the treatment approaches used today throughout the country.
- A patient-centered approach, ensuring you and your loved ones receive the needed medical care and emotional support.
- An interdisciplinary team approach, whereby all your physicians, nurses and other health care professionals work closely together to optimize your care.
- We are one of ten cancer centers in the U.S. who are members of the Sarcoma Alliance for Collaboration through Research (SARC).
Our team of providers is as follows:
Arthur P. Staddon, MD
Lee Hartner, MD
Laetitia Simeral, CRNP, MSN
Geoffrey Geiger, MD
James D. Kolker, MD
Suneel N. Nagda, MD